表紙:医薬品ろ過市場の規模、シェア、動向分析:製品別、システム別、技術別、用途別、運用規模別、地域別展望、競合戦略、2030年までのセグメント別予測
市場調査レポート
商品コード
1089970

医薬品ろ過市場の規模、シェア、動向分析:製品別、システム別、技術別、用途別、運用規模別、地域別展望、競合戦略、2030年までのセグメント別予測

Pharmaceutical Filtration Market Size, Share & Trends Analysis By Product, By Systems, By Technique, By Application, By Scale of Operation, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030

出版日: | 発行: SPER Market Research Pvt. Ltd. | ページ情報: 英文 208 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=136.22円
医薬品ろ過市場の規模、シェア、動向分析:製品別、システム別、技術別、用途別、運用規模別、地域別展望、競合戦略、2030年までのセグメント別予測
出版日: 2022年06月13日
発行: SPER Market Research Pvt. Ltd.
ページ情報: 英文 208 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

世界の医薬品ろ過の市場規模は、今後15.6%のCAGRで拡大し、2030年までに361億3,000万米ドルに達すると予測されています。単回使用技術の採用拡大、大手市場関係者による新製品の発売数増加、エンドユーザーセグメントにおける純度要求の高まり、ナノファイバー技術の進歩の増大などが、医薬品ろ過市場の成長に寄与しています。

当レポートでは、世界の医薬品ろ過市場について調査し、市場の概要とともに、製品別、システム別、技術別、用途別、運用規模別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 成長要因、抑制要因、機会、課題の分析
    • 促進要因
    • 抑制要因
    • 市場の機会
    • 課題
  • COVID-19が医薬品ろ過市場に及ぼす影響

第5章 市場変数と見通し

  • SWOT分析
  • PESTEL分析
  • ポーターのファイブフォース分析
  • ヒートマップ分析

第6章 医薬品ろ過市場、製品別、2019年~2030年(100万米ドル)

  • イントロダクション
  • フィルター
  • システム
  • その他

第7章 医薬品ろ過市場、技術別、2019年~2030年(100万米ドル)

  • イントロダクション
  • 精密ろ過
  • 限外ろ過
  • ナノ濾過
  • その他

第8章 医薬品ろ過市場、タイプ別、2019年~2030年(100万米ドル)

  • イントロダクション
  • 滅菌ろ過
  • 非滅菌ろ過

第9章 医薬品ろ過市場、用途別、2019年~2030年(100万米ドル)

  • イントロダクション
  • 最終製品の処理
  • 原料ろ過
  • 細胞分離
  • 水の浄化
  • 空気清浄

第10章 医薬品ろ過市場、運用業規模別、2019年~2030年(100万米ドル)

  • イントロダクション
  • 製造規模の運用
  • パイロット規模の運用
  • 研究開発規模の運用

第11章 医薬品ろ過市場、地域別、2019年~2030年(100万米ドル)

  • 北米
  • 欧州
  • アジア太平洋
  • 南米
  • 中東・アフリカ

第12章 企業プロファイル

  • Alfa Laval Corporate AB
  • Amazon Filters LTD.
  • Cantel Medical Corp.
  • Cole-Parmer Instrument Company LCC.
  • Corning Incorporated.
  • Donaldson Company, Inc.
  • Danaher Corporation
  • Eaton Corporation PLC.
  • Ertelalsop
  • Filtrox AG.
  • Freudenberg Filtration Technologies SE & CO.KG
  • Graver Technologies, LLC.
  • Kasag Swiss AG.
  • Membrane Solutions
  • Merck KGAA.
  • MMS AG
  • Mann + Hummel International GMBH & CO. KG
  • Meissner Filtration Products, INC.
  • Parker + Hannifin Corporation
  • Porvair PLC.
  • Repligen Corporation.
  • Saint-Gobain Performance Plastics.
  • Sartorius AG.
  • 3M Company
目次
Product Code: BIOT2228

Pharmaceutical Filtration Services Market is projected to be worth USD 36.13 billion by 2030.

According to SPER Market Research, the Pharmaceutical Filtration Market is estimated to reach USD 36.13 billion by 2030 with a CAGR of 15.6%. The increasing adoption of single-use technologies, a rising number of new product launches by leading market players, increasing purity requirements in end user segments, and increasing advances in nanofiber technology are all contributing to the pharmaceutical filtration market's growth. Membrane fouling, on the other hand, is expected to supress market growth, as is the high capital investment required to set up new manufacturing facilities.

Impact of COVID-19 on the Pharmaceutical Filtration Market

With the World Health Organization (WHO) calling the COVID-19 outbreak a pandemic, a number of prominent pharmaceutical and biopharmaceutical businesses have increased their R&D and production efforts to create and market SARS-CoV-2 viral test kits, vaccines, and treatments. The pandemic's economic and social costs have driven governments around the world to increase funding for vaccine development and production, resulting in a rise in the use of pharmaceutical filtration products in COVID-19 research and production. In the research and manufacture of vaccinations, many filtration technologies are utilized.

Scope of the report:

  • Market size available for years: 2019-2030
  • Base year considered: 2021
  • Forecast period: 2022-2030
  • Segments covered: By Product, By Systems, By Technique, By Application, By Scale of Operation
  • Geographies covered: North America, Europe, Asia Pacific, Latin America, Middle East, Africa
  • Companies Covered: Alfa Laval Corporate AB, Amazon Filters LTD, Cantel Medical Corp., Cole-Parmer Instrument Company LCC., Corning Incorporated., Donaldson Company, Inc., Danaher Corporation, Eaton Corporation PLC., Ertelalsop, Filtrox AG., Freudenberg Filtration Technologies SE & CO.KG, Graver Technologies, LLC., Kasag Swiss AG., Membrane Solutions., Merck KGAA. , MMS AG., Mann + Hummel International GMBH & CO. KG, Meissner Filtration Products, INC., Parker + Hannifin Corporation , Porvair PLC. , Repligen Corporation., Saint-Gobain Performance Plastics. , Sartorius AG. , 3M Company.

Driver: Increase adoption of Single use technologies.

Single-use technologies require less space, capital investment, and sterilization than reusable systems. This lowers the total operating and maintenance expenses as well as the impact of these activities on the environment. End users have been able to attain regulatory compliance for their processes at a lower cost using these solutions. As a result, single-use or disposable solutions have proven to be a key technical advancement in the pharmaceutical filtration sector, with their enormous benefits driving end-user demand and, by extension, market expansion.

Restraint: Challanges in membrane fouling to restain market growth.

When compared to other filtration technologies such as tubular or spiral-wound components, these filters are more prone to break due to the flexibility of the fibers. In comparison to alternative arrangements, membrane filters have reasonable capital costs but high operating expenses. Pharmaceutical filters in biopharmaceutical filtering processes are difficult to use because of their high cost and membrane fouling concerns.

Opportunity: Nanofiltration can benefits from advancements in nanofiber technology.

Nanofiltration, which separates molecules present in organic solvents, has a lot of potential in sectors ranging from refining to fine chemical and pharmaceutical production. As a result, market growth is likely to be driven by advancements in nanofiber technology throughout the forecast period.

Challenges: Increased cost reduced speed and yield.

Pharmaceutical filters are subjected to comprehensive lot release testing to verify that they operate to specifications. Manufacturers execute 100 percent integrity testing on sterilizing filters, as well as relevant validation tests, to verify conformity with specified requirements. Some bigger producers do further lot release testing to determine the amount of germs retained in each lot. In-house testing necessitates costly equipment and carefully qualified experts, raising the price of pharmaceutical filters. Additionally, because some present downstream activities, such as nanofiltration, are not compatible with continuous processing, speed of processing and avoiding bottlenecks are part of the efficiency problem. This diminishes yield and increases the amount of time and effort required, posing problems for subsequent processing.

Pharmaceutical Filtration Market, By Product:

Based on the Product of Pharmaceutical Filtration Market is segment as; Filters [Membrane Filters {Polyethersulfone (PES), Polyvinylidene Difluoride (PVDF), Nylon, Polyetrafluoroethylene (PTFE), Mixed Cellulose Ester & Cellulose Acetate (MCE & CA), Polycarbonate Tracked Etched (PCTE), Other Materials}], Depth Filters [{Diatomaceous Earth (Diatomaceous Earth to be used in-depth filters in biotechnology industry for cell clarification)} , {Cellulose (Cost-effectiveness of cellulose-based depth filter to drive market growth)}, {Activated Carbon (Reliable and economic activated carbon filters to be used in traditional pharmaceutical manufacturing operations)}, {Perlite (Perlite is lower in density to provide more purity than diatomaceous earth)}, Other Depth Filter Media ] , Other Filters, Systems {Single-use systems (Reduced need for product validation and minimized cross-contamination risk to boost single-use systems adoption)}, {Reusable systems (Reusable systems to be used for large-scale manufacturing)}, Other Filtration Products {Filtration Assemblies, Filter Holder (Filter holders to provide structural support to membrane filters), Filtration Accessories( Increased in pharmaceutical filtration products adoption to support associated accessories used)}.

Pharmaceutical Filtration Market, By Techniques:

Based on the Techniques of Pharmaceutical Filtration Market is segment as; Microfiltration (Increased adoption of Microfiltration Technique and cost-effective nature to propel Market growth), Ultrafiltration (Adoption of Fine Filtration Technique to drive Market growth), Nanofiltration (High energy Consumption to hider Market growth) Other Techniques (High Purity water requirement during Biopharmaceutical manufacturing to increase Market growth).

Pharmaceutical Filtration Market, By Types:

Based on the Types of Pharmaceutical Filtration Market is segment as; Sterile Filtration (Increased manufacturing of Bilogics drugs to drive sterile filtration demand), Non -Sterile Filtration (Growth of R&D activities to promote Market growth).

Pharmaceutical Filtration Market, By Applications:

Based on the Applications of Pharmaceutical Filtration Market is segment as; Final Product Processing {Active Pharmaceutical Ingredient (API) Filtration (Continuous filtration of API filtration to increase market growth), Protein Purification (Recent advancement in protein therapeutic drugs to propel market growth) , Vaccine and Antibody Processing (Rise in COVID-19 pandemic and other viral diseases to drive vaccine and antibody processing market), Formulation and Filling Solutions (Demand for aseptic filling and bioburden reduction to increase market growth), Viral Clearance (Growth in therapeutic monoclonal antibodies to increase market growth)}, Raw Materials Filtration {Media Buffer Filtration (Growth in manufacturing of biopharmaceuticals to improve market growth), Prefiltration (Membrane fouling to increase market growth for prefilters) , Bioburden Testing (Strict quality control of biopharmaceuticals to improve market growth)}, Cell Separation (Growth in personalized medicine to improve market growth), Water Purification ( Growth in aged population to improve market growth) , Air Purification (Increased adoption of GMP practices to improve market growth)}.

Pharmaceutical Filtration Services Market, By Scale of Operation:

Based on the Scale of Operation of Pharmaceutical Filtration Market is segment as; Manufacturing Scale Operation (Expansion by pharmaceuticals to manufacture Covid-19 drugs to drive market growth), Pilot Scale Operation (Increased outsourcing and cost-effective nature to promote market growth), R&D Scale Operation (Expenditure for R&D of Biologics to increase market growth).

Pharmaceutical Filtration Services Market, By Region:

North America and Asia-Pacific region owns the prime share of this market due to rising incidence rate of viral diseases, the need to maintain a clean manufacturing environment because of strict regulatory rule.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1 Research data source
    • 2.1.1 Secondary data
    • 2.1.2 Primary data
    • 2.1.3 SPER's internal database
    • 2.1.4 Premium insight from KOL's
  • 2.2 Market size estimation
    • 2.2.1 Top-down and Bottom-up approach
  • 2.3 Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1 Drivers
    • 4.1.2 Restraints
    • 4.1.3 Opportunities
    • 4.1.4 Challenges
  • 4.2. COVID-19 Impacts of the Pharmaceutical Filtration Market

5. Market variables and outlook

  • 5.1. SWOT analysis
    • 5.1.1 Strengths
    • 5.1.2 Weaknesses
    • 5.1.3 Opportunities
    • 5.1.4 Threats
  • 5.2. PESTEL analysis
    • 5.2.1 Political landscape
    • 5.2.2 Economic landscape
    • 5.2.3 Social landscape
    • 5.2.4 Technological landscape
    • 5.2.5 Environmental landscape
    • 5.2.6 Legal landscape
  • 5.3. PORTER'S five forces analysis
    • 5.3.1 Bargaining power of suppliers
    • 5.3.2 Bargaining power of Buyers
    • 5.3.3 Threat of Substitute
    • 5.3.4 Threat of new entrant
    • 5.3.5 Competitive rivalry
  • 5.4. Heat map analysis

6. Pharmaceutical Filtration Market, By Product, 2019-2030 (USD Million)

  • 6.1 Introduction
  • 6.2. Filter
    • 6.2.1 Membrane Filters

6.2.1.1.Polyethersulfone (PES)

      • 6.2.1.2 Polyvinylidene difluoride (PVDF)
      • 6.2.1.3 Nylon
      • 6.2.1.4 Polytetrafluroethylene (PTFE)
      • 6.2.1.5. Mixed cellulose ester & cellulose acetate (MCE & CA)
      • 6.2.1.6 Polycarbonated Track-Etched (PCTE)
      • 6.2.1.7 Other materials
    • 6.2.2 Depth Filters
      • 6.2.2.1 Diatomaceous earth
        • 6.2.2.1.1. Diatomaceous Earth to be used in-depth filters in biotechnology industry for cell clarification
      • 6.2.2.2 Cellulose
        • 6.2.2.2.1. Cost-effectiveness of cellulose-based depth filter to drive market growth.
      • 6.2.2.3 Activated Carbon
        • 6.2.2.3.1. Reliable and economic activated carbon filters to be used in traditional pharmaceutical manufacturing operations.
      • 6.2.2.4 Perlite
        • 6.2.2.4.1. Perlite is lower in density to provide more purity than diatomaceous earth
      • 6.2.2.5 Other Depth Filter Media
    • 6.2.3 Other Filters
  • 6.3 Systems
    • 6.3.1 Single-use systems
      • 6.3.1.1. Reduced need for product validation and minimized cross-contamination risk to boost single-use systems adoption
    • 6.3.2 Reusable systems
      • 6.3.2.1. Reusable systems to be used for large-scale manufacturing
  • 6.4 Other Filtration Products
    • 6.4.1 Filtration Assemblies
    • 6.4.2 Filter Holder
      • 6.4.2.1. Filter holders to provide structural support to membrane filters
    • 6.4.3 Filtration Accessories
      • 6.4.3.1. Increase in pharmaceutical filtration products adoption to support associated accessories used

7. Pharmaceutical Filtration Market, By Technique, 2019-2030 (USD Million)

  • 7.1. Introduction
  • 7.2. Microfiltration
    • 7.2.1. Increased adoption of Microfiltration Technique and cost-effective nature to propel Market growth
  • 7.3. Ultrafiltration
    • 7.3.1. Adoption of Fine Filtration Technique to drive Market growth
  • 7.4. Nanofiltration
    • 7.4.1. High energy Consumption to hider Market growth
  • 7.5. Other Techniques
    • 7.5.1. High Purity water requirement during Biopharmaceutical manufacturing to increase Market growth

8. Pharmaceutical Filtration Market, By Type, 2019-2030 (USD Million)

  • 8.1. Introduction
  • 8.2. Sterile Filtration
    • 8.2.1. Increased manufacturing of Bilogics drugs to drive sterile filtration demand.
  • 8.3. Non sterile Filtration
    • 8.3.1. Growth of R&D activities to promote Market growth

9. Pharmaceutical Filtration Market, By Applications, 2019-2030 (USD Million)

  • 9.1 Introduction
  • 9.2 Final Product Processing
    • 9.2.1 Active Pharmaceutical Ingredients (API) Filtration
      • 9.2.1.1. Continuous filtration of API filtration to increase market growth
    • 9.2.2 Protein Purification
      • 9.2.2.1. Recent advancement in protein therapeutic drugs to propel market growth
    • 9.2.3 Vaccine and Antibody Processing
      • 9.2.3.1. Rise in COVID-19 pandemic and other viral diseases to drive vaccine and antibody processing market
    • 9.2.4 Formulation and Filling Solutions
      • 9.2.4.1. Demand for aseptic filling and bioburden reduction to increase market growth
    • 9.2.5 Viral Clearance
      • 9.2.5.1. Growth in therapeutic monoclonal antibodies to increase market growth
  • 9.3 Raw Material Filtration
    • 9.3.1 Media Buffer Filtration
      • 9.3.1.1. Growth in manufacturing of biopharmaceuticals to improve market growth
    • 9.3.2 Prefiltration
      • 9.3.2.1. Membrane fouling to increase market growth for prefilters
    • 9.3.3 Bioburden Testing
      • 9.3.3.1. Strict quality control of biopharmaceuticals to improve market growth
  • 9.4 Cell Seperation
    • 9.4.1. Growth in personalized medicine to improve market growth
  • 9.5 Water Purification
    • 9.5.1. Growth in aged population to improve market growth
  • 9.6 Air Purification
    • 9.6.1. Increased adoption of GMP practices to improve market growth

10. Pharmaceutical Filtration Market, By Scale of Operation 2019-2030 (USD Million)

  • 10.1 Introduction
  • 10.2 Manufacturing-Scale Operation
    • 10.2.1. Expansion by pharmaceuticals to manufacture Covid-19 drugs to drive market growth
  • 10.3 Pilot-Scale Operation
    • 10.3.1. Increased outsourcing and cost-effective nature to promote market growth
  • 10.4 R&D-Scale of Operation
    • 10.4.1. Expenditure for R&D of Biologics to increase market growth

11. Pharmaceutical Filtration Market by Region, 2019-2030 (USD Million)

  • 11.1. North America
    • 11.1.1. United States
    • 11.1.2. Canada
    • 11.1.3. Mexico
  • 11.2. Europe
    • 11.2.1. Germany
    • 11.2.2. United Kingdom
    • 11.2.3. France
    • 11.2.4. Italy
    • 11.2.5. Spain
    • 11.2.6. Rest of Europe
  • 11.3. Asia-Pacific
    • 11.3.1. China
    • 11.3.2. Japan
    • 11.3.3. India
    • 11.3.4. Australia
    • 11.3.5. South Korea
    • 11.3.6. Rest of Asia-Pacific
  • 11.4. South America
    • 11.4.1. Brazil
    • 11.4.2. Argentina
    • 11.4.3. Rest of South America
  • 11.5. Middle East & Africa
    • 11.5.1. Kingdom of Saudi Arabia
    • 11.5.2. United Arab Emirates
    • 11.5.3. Rest of Middle East & Africa

12. Company Profiles

  • 12.1. Alfa Laval Corporate AB
    • 12.1.1. Company details
    • 12.1.2. Financial outlook
    • 12.1.3. Product summary
    • 12.1.4. Recent developments
  • 12.2. Amazon Filters LTD.
    • 12.2.1. Company details
    • 12.2.2. Financial outlook
    • 12.2.3. Product summary
    • 12.2.4. Recent developments
  • 12.3. Cantel Medical Corp.
    • 12.3.1. Company details
    • 12.3.2. Financial outlook
    • 12.3.3. Product summary
    • 12.3.4. Recent developments
  • 12.4. Cole-Parmer Instrument Company LCC.
    • 12.4.1. Company details
    • 12.4.2. Financial outlook
    • 12.4.3. Product summary
    • 12.4.4. Recent developments
  • 12.5. Corning Incorporated.
    • 12.5.1. Company details
    • 12.5.2. Financial outlook
    • 12.5.3. Product summary
    • 12.5.4. Recent developments
  • 12.6. Donaldson Company, Inc.
    • 12.6.1. Company details
    • 12.6.2. Financial outlook
    • 12.6.3. Product summary
    • 12.6.4. Recent developments
  • 12.7. Danaher Corporation
    • 12.7.1. Company details
    • 12.7.2. Financial outlook
    • 12.7.3. Product summary
    • 12.7.4. Recent developments
  • 12.8. Eaton Corporation PLC.
    • 12.8.1. Company details
    • 12.8.2. Financial outlook
    • 12.8.3. Product summary
    • 12.8.4. Recent developments
  • 12.9. Ertelalsop
    • 12.9.1. Company details
    • 12.9.2. Financial outlook
    • 12.9.3. Product summary
    • 12.9.4. Recent developments
  • 12.10. Filtrox AG.
    • 12.10.1. Company details
    • 12.10.2. Financial outlook
    • 12.10.3. Product summary
    • 12.10.4. Recent developments
  • 12.11. Freudenberg Filtration Technologies SE & CO.KG
    • 12.11.1. Company details
    • 12.11.2. Financial outlook
    • 12.11.3. Product summary
    • 12.11.4. Recent developments
  • 12.12. Graver Technologies, LLC.
    • 12.12.1. Company details
    • 12.12.2. Financial outlook
    • 12.12.3. Product summary
    • 12.12.4. Recent developments
  • 12.13. Kasag Swiss AG.
    • 12.13.1. Company details
    • 12.13.2. Financial outlook
    • 12.13.3. Product summary
    • 12.13.4. Recent developments
  • 12.14. Membrane Solutions.
    • 12.14.1. Company details
    • 12.14.2. Financial outlook
    • 12.14.3. Product summary
    • 12.14.4. Recent developments
  • 12.15. Merck KGAA.
    • 12.15.1. Company details
    • 12.15.2. Financial outlook
    • 12.15.3. Product summary
    • 12.15.4. Recent developments
  • 12.16. MMS AG
    • 12.16.1. Company details
    • 12.16.2. Financial outlook
    • 12.16.3. Product summary
    • 12.16.4. Recent developments
  • 12.17. Mann + Hummel International GMBH & CO. KG
    • 12.17.1. Company details
    • 12.17.2. Financial outlook
    • 12.17.3. Product summary
    • 12.17.4. Recent developments
  • 12.18. Meissner Filtration Products, INC.
    • 12.18.1. Company details
    • 12.18.2. Financial outlook
    • 12.18.3. Product summary
    • 12.18.4. Recent developments
  • 12.19. Parker + Hannifin Corporation.
    • 12.19.1. Company details
    • 12.19.2. Financial outlook
    • 12.19.3. Product summary
    • 12.19.4. Recent developments
  • 12.20. Porvair PLC.
    • 12.20.1. Company details
    • 12.20.2. Financial outlook
    • 12.20.3. Product summary
    • 12.20.4. Recent developments
  • 12.21. Repligen Corporation.
    • 12.21.1. Company details
    • 12.21.2. Financial outlook
    • 12.21.3. Product summary
    • 12.21.4. Recent developments
  • 12.22. Saint-Gobain Performance Plastics.
    • 12.22.1. Company details
    • 12.22.2. Financial outlook
    • 12.22.3. Product summary
    • 12.22.4. Recent developments
  • 12.23. Sartorius AG.
    • 12.23.1. Company details
    • 12.23.2. Financial outlook
    • 12.23.3. Product summary
    • 12.23.4. Recent developments
  • 12.24. 3M Company.
    • 12.24.1. Company details
    • 12.24.2. Financial outlook
    • 12.24.3. Product summary
    • 12.24.4. Recent developments

11. Pharmaceutical Filtration Market by Region, 2019-2030 (USD Million)

  • 11.1. North America
    • 11.1.1. United States
    • 11.1.2. Canada
    • 11.1.3. Mexico
  • 11.2. Europe
    • 11.2.1. Germany
    • 11.2.2. United Kingdom
    • 11.2.3. France
    • 11.2.4. Italy
    • 11.2.5. Spain
    • 11.2.6. Rest of Europe
  • 11.3. Asia-Pacific
    • 11.3.1. China
    • 11.3.2. Japan
    • 11.3.3. India
    • 11.3.4. Australia
    • 11.3.5. South Korea
    • 11.3.6. Rest of Asia-Pacific
  • 11.4. South America
    • 11.4.1. Brazil
    • 11.4.2. Argentina
    • 11.4.3. Rest of South America
  • 11.5. Middle East & Africa
    • 11.5.1. Kingdom of Saudi Arabia
    • 11.5.2. United Arab Emirates
    • 11.5.3. Rest of Middle East & Africa

12. Company Profiles

  • 12.1. Alfa Laval Corporate AB
    • 12.1.1. Company details
    • 12.1.2. Financial outlook
    • 12.1.3. Product summary
    • 12.1.4. Recent developments
  • 12.2. Amazon Filters LTD.
    • 12.2.1. Company details
    • 12.2.2. Financial outlook
    • 12.2.3. Product summary
    • 12.2.4. Recent developments
  • 12.3. Cantel Medical Corp.
    • 12.3.1. Company details
    • 12.3.2. Financial outlook
    • 12.3.3. Product summary
    • 12.3.4. Recent developments
  • 12.4. Cole-Parmer Instrument Company LCC.
    • 12.4.1. Company details
    • 12.4.2. Financial outlook
    • 12.4.3. Product summary
    • 12.4.4. Recent developments
  • 12.5. Corning Incorporated.
    • 12.5.1. Company details
    • 12.5.2. Financial outlook
    • 12.5.3. Product summary
    • 12.5.4. Recent developments
  • 12.6. Donaldson Company, Inc.
    • 12.6.1. Company details
    • 12.6.2. Financial outlook
    • 12.6.3. Product summary
    • 12.6.4. Recent developments
  • 12.7. Danaher Corporation
    • 12.7.1. Company details
    • 12.7.2. Financial outlook
    • 12.7.3. Product summary
    • 12.7.4. Recent developments
  • 12.8. Eaton Corporation PLC.
    • 12.8.1. Company details
    • 12.8.2. Financial outlook
    • 12.8.3. Product summary
    • 12.8.4. Recent developments
  • 12.9. Ertelalsop
    • 12.9.1. Company details
    • 12.9.2. Financial outlook
    • 12.9.3. Product summary
    • 12.9.4. Recent developments
  • 12.10. Filtrox AG.
    • 12.10.1. Company details
    • 12.10.2. Financial outlook
    • 12.10.3. Product summary
    • 12.10.4. Recent developments
  • 12.11. Freudenberg Filtration Technologies SE & CO.KG
    • 12.11.1. Company details
    • 12.11.2. Financial outlook
    • 12.11.3. Product summary
    • 12.11.4. Recent developments
  • 12.12. Graver Technologies, LLC.
    • 12.12.1. Company details
    • 12.12.2. Financial outlook
    • 12.12.3. Product summary
    • 12.12.4. Recent developments
  • 12.13. Kasag Swiss AG.
    • 12.13.1. Company details
    • 12.13.2. Financial outlook
    • 12.13.3. Product summary
    • 12.13.4. Recent developments
  • 12.14. Membrane Solutions.
    • 12.14.1. Company details
    • 12.14.2. Financial outlook
    • 12.14.3. Product summary
    • 12.14.4. Recent developments
  • 12.15. Merck KGAA.
    • 12.15.1. Company details
    • 12.15.2. Financial outlook
    • 12.15.3. Product summary
    • 12.15.4. Recent developments
  • 12.16. MMS AG
    • 12.16.1. Company details
    • 12.16.2. Financial outlook
    • 12.16.3. Product summary
    • 12.16.4. Recent developments
  • 12.17. Mann + Hummel International GMBH & CO. KG
    • 12.17.1. Company details
    • 12.17.2. Financial outlook
    • 12.17.3. Product summary
    • 12.17.4. Recent developments
  • 12.18. Meissner Filtration Products, INC.
    • 12.18.1. Company details
    • 12.18.2. Financial outlook
    • 12.18.3. Product summary
    • 12.18.4. Recent developments
  • 12.19. Parker + Hannifin Corporation.
    • 12.19.1. Company details
    • 12.19.2. Financial outlook
    • 12.19.3. Product summary
    • 12.19.4. Recent developments
  • 12.20. Porvair PLC.
    • 12.20.1. Company details
    • 12.20.2. Financial outlook
    • 12.20.3. Product summary
    • 12.20.4. Recent developments
  • 12.21. Repligen Corporation.
    • 12.21.1. Company details
    • 12.21.2. Financial outlook
    • 12.21.3. Product summary
    • 12.21.4. Recent developments
  • 12.22. Saint-Gobain Performance Plastics.
    • 12.22.1. Company details
    • 12.22.2. Financial outlook
    • 12.22.3. Product summary
    • 12.22.4. Recent developments
  • 12.23. Sartorius AG.
    • 12.23.1. Company details
    • 12.23.2. Financial outlook
    • 12.23.3. Product summary
    • 12.23.4. Recent developments
  • 12.24. 3M Company.
    • 12.24.1. Company details
    • 12.24.2. Financial outlook
    • 12.24.3. Product summary
    • 12.24.4. Recent developments